Delivery Order SPE2DB20D1110-SPE2DB24FJ89Y
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as a firm fixed price delivery order for the supply of Corlanor 5 mg tablets. The total ceiling value of the award is $2,114.52, with a period of performance through April 2, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,906.87, is for the delivery of Corlanor 5 mg tablets. It is a firm fixed-price delivery order contract that runs through January 30, 2024. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,984.27, is for the delivery of the medication Corlanor 5 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,941.10 Firm Fixed Price Delivery Order contract is for the supply of the prescription medication Corlanor 5 mg tablets. The contract has an ultimate completion date of May 3, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.07 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,893.93, is for the delivery of the medication Corlanor 7.5 mg tablets. The contract has a period of performance through December 1, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,323.16, is for the delivery of the medication Corlanor 5 mg tablets. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,114.52 firm-fixed-price delivery order contract is for the supply of CORLANOR 5 MG TABLET 60S, a cardiovascular medication. The contract is not designated as a set-aside and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,059.99 firm fixed-price delivery order is for the supply of Corlanor 5 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Corlanor 5 mg tablets, a medication used for the treatment of chronic heart failure. The award has a ceiling value of $5,924.88 and an ultimate completion date of October 28, 2024. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FJ89YDelivery Order
This federal contract award, with the ID SPE2DB20D1110|SPE2DB24FJ89Y, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Corlanor 5 mg tablets, a cardiovascular medication, and has a ceiling value of $1,130.52. The contract has an ultimate completion date of January 26, 2024 and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Both companies are for-profit organizations registered in the System for Award Management (SAM.gov). Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/25/24 |